Eric Andersen, Director at MERRIMACK PHARMACEUTICALS INC (MACK), bought 221,550 shares at $12.00 ($2.7M) on 2023-08-07, disclosed to the SEC on 2023-08-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.00 | 49,857 | $598K | 22.5% |
| 2 | $12.00 | 84,636 | $1.0M | 38.2% |
| 3 | $12.00 | 18,626 | $224K | 8.4% |
| 4 | $12.00 | 68,431 | $821K | 30.9% |
| Total | $12.00 avg | 221,550 | $2.7M | 100% |
| Filing → |
| MACK | BUY | 2023-12-11 | $2.6M | — | Filing → |
| MACK | BUY | 2023-11-14 | $1.3M | — | Filing → |
| AON | SELL | 2023-05-11 | $2.5M | — | Filing → |